Effects of telmisartan on fat distribution: a meta-analysis of randomized controlled trials.
CONCLUSION: The findings suggest that telmisartan affected fat distribution, inducing visceral fat reduction, and thus, could be useful in hypertensive patients with obesity/overweight, metabolic syndrome, or glucose intolerance.
PMID: 27010868 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
More News: Cholesterol | Databases & Libraries | Eating Disorders & Weight Management | Metabolic Syndrome | Obesity | Research | Study